Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a histiocytic disorder at any age, which includes any of the following conditions: Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, Xanthogranuloma, Mixed histiocytosis, Malignant histiocytosis (including Histiocytic sarcoma, Langerhans cell sarcoma, or Interdigitating cell sarcoma), or Hemophagocytic lymphohistiocytosis.
Who may not be able to join:
- There are no listed exclusion criteria for this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gaurav Goyal, MD, University of Alabama at Birmingham
Phone: 1-866-438-1640
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Chronic health conditions diagnosed after LCH diagnosis graded using the Common Terminology Criteria for Adverse Events (CTCAE), v5.0 (https://ctep.cancer.gov); All-cause and cause-specific mortality
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.